3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
1
Status
Completed
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
Sarcoma
1
Conditions
Sarcoma, Synovial
1
Sarcoma
1
Rhabdomyosarcoma
1
Recurrence
1
Medulloblastoma
1
Ependymoma
1
Brain Neoplasms
1
Interventions
Doxorubicin
11
Ifosfamide
9
Radiotherapy
6
tazemetostat
4
pegfilgrastim
3
cixutumumab
3
Imatinib Mesylate
3
Filgrastim
3
Cyclophosphamide
3
pazopanib
2
Trabectedin
2
Sunitinib
2
Sorafenib
2
Etoposide
2
Dacarbazine
2
Chemotherapy, Adjuvant
2
trofosfamide
1
tremelimumab
1
temsirolimus
1
soblidotin
1
sargramostim
1
romidepsin
1
ribociclib
1
reolysin
1
poly ICLC
1
perifosine
1
pembrolizumab
1
lorvotuzumab mertansine
1
liposomal doxorubicin
1
ixabepilone
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Completed
×
Sarcoma, Synovial
×
trofosfamide
×
Clear all
NCT00876031
2022-11-08
CWS-2007-HR
University Hospital Tuebingen
Phase 3
Completed
195 enrolled